|
| 国际皮肤性病学杂志 2001 27 (6): 369-370 ISSN: 2096-5540 CN: 32-1880/R |
|
|
|
|
|
| 一类新的抗银屑病制剂——过氧化物酶体增殖蛋白激活性受体γ配体 |
| 吴颖编译, 吕昭萍审校 |
| 昆明医学院第一附属医院皮肤科 |
| 收稿日期 null 修回日期 null 网络版发布日期 null |
参考文献 [1] Ellis CN,Varani J,Fisher GJ,et al.Troglitazone impiroves psoriasis andnormalizes models of proliferative skin disease.Arch Dermatol,2000,136:609-616.
[2] Clark RB,Bishop-Bailey D,Estrada-hemandez T,et al.The nuclear recep tor PPARyand immunoregulation:PPARγ mediates inhibition of helper T cell responses.J Immunol,2000,164(3):1364-1371.
[3] Jiang CY,Ting AT,Seed B.PPAR-γ agonists inhibit production of monocyte inflammatory cytokines.Nature,1998,391 (6662):82-86. |
|
|
|
| 通讯作者: |
|